Current strategies for the prevention and management of central line-associated bloodstream infections

Central venous catheters are an invaluable tool for diagnostic and therapeutic purposes in today’s medicine, but their use can be complicated by bloodstream infections (BSIs). While evidence-based preventive measures are disseminated by infection control associations, the optimal management of established central line-associated BSIs has been summarized in infectious diseases guidelines. We prepared an overview of the state-of-the-art of prevention and management of central line-associated BSIs and included topics such as the role of antibiotic-coated catheters, the role of catheter removal in the management, and a review of currently used antibiotic compounds and the duration of treatment.

[1]  H. Danawi,et al.  Management of central venous catheters in patients with cancer and candidemia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  I. Raad,et al.  Management of Bacillus Bacteremia: The Need for Catheter Removal , 2009, Medicine.

[3]  I. Gadea,et al.  Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia , 2002, Journal of internal medicine.

[4]  L. Szczech,et al.  Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Vance G Fowler,et al.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. , 2006, The New England journal of medicine.

[6]  Peter J Pronovost,et al.  Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.

[7]  P. Lebecque,et al.  Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  L. Mermel,et al.  Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[9]  J. Sasadeusz,et al.  Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies. , 2008, The Journal of infection.

[10]  K. Chan,et al.  Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. , 1993, Journal of the American College of Cardiology.

[11]  P. Martín-Dávila,et al.  Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. , 2006, The Journal of antimicrobial chemotherapy.

[12]  M. Samore,et al.  Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. , 1995, Archives of internal medicine.

[13]  P. Diggle,et al.  A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Á. Soriano,et al.  Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms , 2010, Antimicrobial Agents and Chemotherapy.

[15]  Y. Harihara,et al.  Maximal Sterile Barrier Precautions Do Not Reduce Catheter-Related Bloodstream Infections in General Surgery Units: A Multi-Institutional Randomized Controlled Trial , 2010, Annals of surgery.

[16]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[17]  M. Jadoul,et al.  Catheter-related blood stream infections (CRBSI): a European view. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  D. Maki,et al.  Intravascular catheter-related infections: advances in diagnosis, prevention, and management. , 2007, The Lancet. Infectious diseases.

[19]  L. Wise,et al.  Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. , 2008, Surgery.

[20]  M. Falagas,et al.  Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. , 2007, European journal of pharmacology.

[21]  C. Carpenter,et al.  Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Linda J Stang,et al.  Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. , 2005, The Journal of antimicrobial chemotherapy.

[23]  F Golliot,et al.  Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. , 2001, JAMA.

[24]  F. Martínez Sagasti,et al.  Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. , 2010, JAMA.

[25]  N. Sucu,et al.  Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. , 2007, JPEN. Journal of parenteral and enteral nutrition.

[26]  L. Ginzton,et al.  Transesophageal echocardiography in diagnosis of infective endocarditis. , 1994, Chest.

[27]  J. L. Iribarren,et al.  Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site* , 2007, Critical care medicine.

[28]  M. Rupp,et al.  Ethanol Lock Technique: Review of the Literature , 2009, Infection Control & Hospital Epidemiology.

[29]  C. Schorr Chlorhexidine-Impregnated Sponges and Less Frequent Dressing Changes for Prevention of Catheter-Related Infections in Critically Ill Adults: A Randomized Controlled Trial , 2010 .

[30]  D. Snydman,et al.  Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. , 1995, Archives of internal medicine.

[31]  L. Elting,et al.  Septicemia Due to Xanthomonas Species and Non‐Aeruginosa Pseudomonas Species: Increasing Incidence of Catheter‐Related Infections , 1990, Medicine.

[32]  John M. Starmer,et al.  Systems initiatives reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. , 2010, The Journal of trauma.

[33]  Stephen J. Wilson,et al.  Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention. , 2006, American journal of infection control.

[34]  M. Taylor,et al.  Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. , 2002, Kidney international.

[35]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  D. Pittet,et al.  Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care , 2000, The Lancet.

[37]  J. L. Del Pozo Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. , 2009, The International journal of artificial organs.

[38]  M. Wagener,et al.  Risk of Infection Due to Central Venous Catheters: Effect of Site of Placement and Catheter Type , 1998, Infection Control & Hospital Epidemiology.

[39]  J. Timsit,et al.  Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. , 2009, JAMA.

[40]  C. Brun-Buisson,et al.  Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures , 1999, The Lancet.

[41]  H. Sax,et al.  Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected. , 2009, The Journal of hospital infection.

[42]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  B. Almirante,et al.  Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. , 2006, The Journal of antimicrobial chemotherapy.

[44]  D. Maki,et al.  Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. , 2005, Chest.

[45]  M. Ghannoum,et al.  Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.

[46]  G. Bodey,et al.  Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions During Insertion , 1994, Infection Control & Hospital Epidemiology.

[47]  J. Leiva,et al.  Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. , 2009, Diagnostic microbiology and infectious disease.

[48]  V. Gill,et al.  Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population , 1987, Journal of clinical microbiology.

[49]  M. Wilcox,et al.  Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. , 2002, The Journal of antimicrobial chemotherapy.

[50]  E. Wong,et al.  A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections , 2006, Infection Control & Hospital Epidemiology.

[51]  G. Bodey,et al.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy , 1994, Antimicrobial Agents and Chemotherapy.

[52]  E. Anaissie,et al.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. , 1993, The Journal of infectious diseases.

[53]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[54]  M. Wallen,et al.  Optimal timing for intravenous administration set replacement. , 2005, Anesthesia and Analgesia.

[55]  J. Jollis,et al.  Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia , 1999, Annals of Internal Medicine.

[56]  L. Lorente,et al.  Central venous catheter-related infection in a prospective and observational study of 2,595 catheters , 2005, Critical care.

[57]  M. Allon Dialysis catheter-related bacteremia: treatment and prophylaxis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  J. Fine,et al.  Meta-Analysis: Methods for Diagnosing Intravascular DeviceRelated Bloodstream Infection , 2005, Annals of Internal Medicine.

[59]  J. Gavaldà,et al.  Management of Catheter-Related Staphylococcus aureus Bacteremia: When May Sonographic Study Be Unnecessary? , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[60]  S. Amyes,et al.  OXA (beta)-lactamases in Acinetobacter: the story so far. , 2006, The Journal of antimicrobial chemotherapy.

[61]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[62]  J. Leiva,et al.  Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. , 2009, International journal of antimicrobial agents.

[63]  L. Peterson,et al.  Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. , 1994, Archives of internal medicine.

[64]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[65]  B. Souweine,et al.  Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. , 2008, JAMA.

[66]  K. Ho,et al.  Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. , 2006, The Journal of antimicrobial chemotherapy.

[67]  S. Hugonnet,et al.  Nosocomial Bacteremia Clinical Significance of a Single Blood Culture Positive for Coagulase-Negative Staphylococci , 2005, Infection Control & Hospital Epidemiology.

[68]  C. Fairley,et al.  Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. , 2002, The Journal of infection.

[69]  T. Perl,et al.  Chlorhexidine: expanding the armamentarium for infection control and prevention. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  M. Allon Treatment guidelines for dialysis catheter-related bacteremia: an update. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  J. Tarrand,et al.  Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse , 2004, Infection Control & Hospital Epidemiology.

[72]  D. Herr,et al.  Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[74]  Stephen E. Muething,et al.  Decreasing PICU Catheter-Associated Bloodstream Infections: NACHRI's Quality Transformation Efforts , 2010, Pediatrics.

[75]  A. Wald,et al.  Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters , 2001, Bone Marrow Transplantation.

[76]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. , 2002, American journal of infection control.

[77]  S. Hugonnet,et al.  Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.

[78]  Sanjay Saint,et al.  Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. , 2002, Annals of internal medicine.

[79]  A. Sturm,et al.  Treatment failure due to extended spectrum beta-lactamase. , 1996, The Journal of antimicrobial chemotherapy.

[80]  D. Shapiro,et al.  Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis , 1997, Journal of clinical microbiology.

[81]  B. Walder,et al.  Complications of central venous catheters: Internal jugular versus subclavian access—A systematic review , 2002, Critical care medicine.

[82]  T. Walley,et al.  The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review* , 2009, Critical care medicine.

[83]  D. Kovacevich,et al.  Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[84]  A. Wilmer,et al.  Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial , 2004, Intensive Care Medicine.

[85]  S. Saint,et al.  Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[86]  K. Papadakis,et al.  Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  W. Onland,et al.  Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. , 2006, Archives of pediatrics & adolescent medicine.

[88]  I. Raad,et al.  The Crucial Role of Catheters in Micrococcal Bloodstream Infections in Cancer Patients , 2009, Infection Control & Hospital Epidemiology.

[89]  K. Farrington,et al.  Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. , 2003, Journal of Antimicrobial Chemotherapy.

[90]  C. Edmiston,et al.  Treatment of Hickman Catheter Sepsis Using Antibiotic Lock Technique , 1995, Infection Control & Hospital Epidemiology.

[91]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  S. Saint,et al.  Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[93]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[94]  P. Patel,et al.  Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  Nnis System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[96]  L. Leibovici,et al.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.

[97]  H. Goossens,et al.  Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  C. Alvarado,et al.  Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1991, The Lancet.

[99]  C. Woods,et al.  Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  Peter J Pronovost,et al.  Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections , 2010, Critical care medicine.

[101]  T. Greene,et al.  Effect of change in vascular access on patient mortality in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[102]  Nasia Safdar,et al.  Educational interventions for prevention of healthcare-associated infection: A systematic review , 2007, Critical care medicine.

[103]  J. Barsuk,et al.  Use of simulation-based education to reduce catheter-related bloodstream infections. , 2009, Archives of internal medicine.

[104]  B. Allegranzi,et al.  Role of hand hygiene in healthcare-associated infection prevention. , 2009, The Journal of hospital infection.

[105]  R. Zbinden,et al.  Significance of Staphylococcus lugdunensis Bacteremia: Report of 28 Cases and Review of the Literature , 2008, Infection.

[106]  Jeanne E. Zack,et al.  An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center* , 2003, Critical care medicine.

[107]  Joshua A. Doherty,et al.  Automated Surveillance for Central Line–Associated Bloodstream Infection in Intensive Care Units , 2008, Infection Control & Hospital Epidemiology.

[108]  C. Salgado,et al.  Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  E. Anaissie,et al.  Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[110]  R. Salomão,et al.  Risk Factors for Death in Patients With Candidemia , 1998, Infection Control & Hospital Epidemiology.

[111]  J. D. Pozo,et al.  Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. , 2009 .

[112]  M. Allon,et al.  Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[113]  W. Peetermans,et al.  Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. , 2005, The Journal of antimicrobial chemotherapy.

[114]  D. K. Benjamin,et al.  Bacteremia, central catheters, and neonates: when to pull the line. , 2001, Pediatrics.

[115]  H. Nemoto,et al.  To reduce catheter-related bloodstream infections: Is the subclavian route better than the jugular route for central venous catheterization? , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[116]  Reduction in central line-associated bloodstream infections among patients in intensive care units--Pennsylvania, April 2001-March 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[117]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[118]  Marin H Kollef,et al.  The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. , 2004, Chest.

[119]  E. Eviatar,et al.  Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. , 2007, Kidney international.

[120]  Walter Zingg,et al.  Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections* , 2009, Critical care medicine.

[121]  A. Dubrow,et al.  Adjunctive Antibiotic/Anticoagulant Lock Therapy in the Treatment of Bacteremia Associated with the Use of a Subcutaneously Implanted Hemodialysis Access Device , 2000, ASAIO journal.

[122]  P. Ganly,et al.  A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. , 2008, The Journal of antimicrobial chemotherapy.

[123]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC / SHEA / APIC / IDSA Hand Hygiene Task Force , 2002 .

[124]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[125]  H. Goossens,et al.  Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). , 2005, Diagnostic microbiology and infectious disease.

[126]  Jerome J. Schentag,et al.  Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2007, Antimicrobial Agents and Chemotherapy.

[127]  L. Rasero,et al.  Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). , 2000, Haematologica.

[128]  C. Libertin,et al.  Endocarditis Complicating Central Venous Catheter Bloodstream Infections: A Unique Form of Health Care Associated Endocarditis , 2009, Clinical cardiology.

[129]  S. Boschi,et al.  Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). , 2000, Haematologica.

[130]  Hugo Sax,et al.  Evidence-based model for hand transmission during patient care and the role of improved practices. , 2006, The Lancet. Infectious diseases.

[131]  B. Debaene,et al.  Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. , 2007, Archives of internal medicine.

[132]  S. Amyes,et al.  OXA β-lactamases in Acinetobacter: the story so far , 2006 .

[133]  Peter J Pronovost,et al.  Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study , 2010, BMJ : British Medical Journal.

[134]  M. Falagas,et al.  Treatment of Acinetobacter infections , 2010 .

[135]  L. Rubin,et al.  Use of disinfectants to reduce microbial contamination of hubs of vascular catheters , 1993, Journal of clinical microbiology.

[136]  P. Gastmeier,et al.  Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial , 2009, Annals of Hematology.

[137]  M. Jadoul,et al.  Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[138]  Á. Soriano,et al.  Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[139]  I. Raad,et al.  Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered? , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[140]  Deborah L. Higgins,et al.  Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[141]  E. Anaissie,et al.  Predictors of adverse outcome in cancer patients with candidemia. , 1998, The American journal of medicine.

[142]  W. Bilker,et al.  Reemergence of gram-negative health care-associated bloodstream infections. , 2006, Archives of internal medicine.

[143]  R. Arbeit,et al.  The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[144]  Robert Sherertz,et al.  Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection , 2000, Annals of Internal Medicine.

[145]  H. Kniemeyer,et al.  Surgical treatment of septic deep venous thrombosis. , 1995, Surgery.

[146]  N. Duncan,et al.  Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[147]  Jeanne E. Zack,et al.  Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit , 2002, Critical care medicine.

[148]  Nasia Safdar,et al.  Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. , 2005, American journal of infection control.

[149]  J. Edgeworth Intravascular catheter infections. , 2009, The Journal of hospital infection.